acetylcysteine has been researched along with mecamylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Friehs, G; Ginzkey, C; Hackenberg, S; Hagen, R; Kleinsasser, NH; Koehler, C; Richter, E; Stueber, T | 1 |
| Bowers, MS; Damaj, MI; Jackson, A; Maldoon, PP | 1 |
1 review(s) available for acetylcysteine and mecamylamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for acetylcysteine and mecamylamine
| Article | Year |
|---|---|
Analysis of nicotine-induced DNA damage in cells of the human respiratory tract.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Bronchi; Cell Line; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Humans; In Situ Nick-End Labeling; Mecamylamine; Mutagens; Nasal Mucosa; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxidative Stress; Respiratory Mucosa | 2012 |
N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
Topics: Acetylcysteine; Animals; Association Learning; Dose-Response Relationship, Drug; Male; Mecamylamine; Mice; Mice, Inbred ICR; Nicotine; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2016 |